FindTrial
Sign In

Best outcome of pelvic exenteration for rectal cancer - An International Multicentre Study

International Benchmarking Study of Pelvic Exenteration for Rectal Cancer (BeSt-PE) - BeSt-PE

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
CTRI
Registry ID
CTRI/2024/09/073200
Enrollment
763
Registered
2024-09-02
Start date
Unknown
Completion date
Unknown
Last updated
2024-09-16

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: K628- Other specified diseases of anus and rectum

Interventions

Intervention1: NA: NA

Sponsors

Surgical Outcomes Research Centre (SOuRCe) at the Royal Prince Alfred Hospital.
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: •Locally advanced primary or locally recurrent adenocarcinoma of the rectum •Total PE (complete en bloc resection of the anus, rectum, genitourinary viscera, reproductive internal organs, regional lymph nodes, and peritoneum)

Exclusion criteria

Exclusion criteria: •Minimally invasive procedures •Synchronous metastases •Palliative intent

Design outcomes

Primary

MeasureTime frame
Perioperative 1)Duration of surgery (minutes) 2)Estimated blood loss (mL) 3)Total length of hospital stay (days) Morbidity and Mortality 1)Comprehensive Complication Index, measured at discharge 2)Return to the operating theatre 3)Mortality, measured at 30 days Oncological 1)R0 resectionTimepoint: 30 Days—

Secondary

MeasureTime frame
NATimepoint: NA—

Countries

Australia, Brazil, India, Japan, Netherlands, New Zealand, Norway, Sweden, Thailand, United Kingdom, United States of America

Contacts

Public ContactDr Avanish Saklani

Tata memorial hospital dr ernest Borges marg parel Mumbai

asaklani@hotmail.com7400319886

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026